Hypertension Journal

Register      Login

VOLUME 2 , ISSUE 2 ( April-June, 2016 ) > List of Articles

RESEARCH ARTICLE

Small Vessel Disease of the Brain and Stroke: Association with Clinic and Ambulatory Blood Pressure

William B White

Citation Information : White WB. Small Vessel Disease of the Brain and Stroke: Association with Clinic and Ambulatory Blood Pressure. Hypertens J 2016; 2 (2):65-73.

DOI: 10.5005/jp-journals-10043-0034

Published Online: 00-06-2016

Copyright Statement:  Copyright © 2016; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

How to cite this article

Gupta P, White WB. Small Vessel Disease of the Brain and Stroke: Association with Clinic and Ambulatory Blood Pressure. Hypertens J 2016;2(2):65-73.


PDF Share
  1. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996 Aug;27(8):1274-1282.
  2. White matter hyperintensities on MRI in the neurologically nondiseased elderly. Analysis of cohorts of consecutive subjects aged 55 to 85 years living at home. Stroke 1995 Jul;26(7):1171-1177.
  3. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol 2010 Jul;9(7):689-701.
  4. C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study. Circulation 2005 Aug;112:900-905.
  5. Heterogeneity of small vessel disease: a systematic review of MRI and histo-pathology correlations. J Neurol Neurosurg Psychiatry 2011 Feb;82(2):126-135.
  6. Cerebral perfusion and cerebrovascular reactivity are reduced in white matter hyperintensities. Stroke 2002 Apr;33(4):972-976.
  7. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013 Aug;12:822-828.
  8. Rapid buildup of brain white matter hyperintensities over 4 years linked to ambulatory blood pressure, mobility, cognition, and depression in old persons. J Gerontol A Biol Sci Med Sci 2013 Nov;68(11):1387-1394.
  9. Cerebral small-vessel disease and decline in information processing speed, executive function and memory. Brain 2005 Sep;128(Pt 9):2034-2041.
  10. Brain white matter hyperintensities, executive dysfunction, instability, and falls in older people: a prospective cohort study. J Gerontol A Biol Sci Med Sci 2012 Oct;67(10):1085-1091.
  11. Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study. Stroke 2010 Apr;41(4):600-606.
  12. Relationship between Apo E, MRI findings, and cognitive function in the Cardiovascular Health Study. Stroke 1998 Feb;29(2):388-398.
  13. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia. Arch Neurol 2008 Jan;65(1):94-100.
  14. Cognitive impairment risk: white matter hyperintensity progression matters. Neurology 2009 Jul;73(2):120-125.
  15. White matter lesions, cognition, and recurrent hemorrahage in lobar intracerebral hemorrhage. Neurology 2004 Nov;63(9):1606-1612.
  16. Severe cerebral white matter hyperintensities predict severe cognitive decline in patients with cerebrovascular disease history. Stroke 2009 Jun;40(6):2219-2221.
  17. Longitudinal cognitive decline in subcortical ischemic vascular disease—the LADIS Study. Cerebrovasc Dis 2009;27(4):384-391.
  18. Subcortical hyperintensities are associated with cognitive decline in patients with mild cognitive impairment. Stroke 2007 Nov;38(11):2924-2930.
  19. Subjective cognitive complaints relate to white matter hyperintensities and future cognitive decline in patients with cardiovascular disease. Am J Geriatr Psychiatry 2009 Nov;17(11):976-985.
  20. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010 Jul;341:c3666.
  21. Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology 2008 Mar;70(12):935-942.
  22. White matter lesions volume and motor performances in the elderly. Ann Neurol 2009 Jun;65(6):706-715.
  23. Prognostic effect of the nocturnal blood pressure fall in hypertensive patients: the ambulatory blood pressure collaboration in patients with hypertension (ABC-H) meta-analysis. Hypertension 2016 Apr;67(4):693-700.
  24. Day-night dip and early-morning surge in blood pressure in hypertension: prognostic implications. Hypertension 2012 Jul;60(1):34-42.
  25. Long-term stroke risk due to partial white-coat or masked hypertension based on home and ambulatory blood pressure measurements: the Ohasama Study. Hypertension 2016 Jan;67(1):48-55.
  26. Ambulatory hypertension subtypes and 24 hour systolic and diastolic blood pressure as distinct outcome predictors in 8341 untreated people recruited from 12 populations. Circulation 2014 Aug;130(6):466-474.
  27. Office, home and ambulatory blood pressures as predictors of cardiovascular risk. Hypertension 2014 Aug;64(2):281-286.
  28. Prognostic impact from clinic, daytime, and night-time systolic blood pressure in nine cohorts of 13,844 patients with hypertension. J Hypertens 2014 Dec;32(12):2332-2340.
  29. The importance of night-time systolic blood pressure in diabetic patients: Dublin Outcome Study. J Hypertens 2015 Jul;33(7):1373-1377.
  30. Both chronic kidney disease and nocturnal blood pressure associate with strokes in the elderly. Am J Nephrol 2013;38(3):195-203.
  31. Prognostic significance of the morning blood pressure surge in clinical practice: a systematic review. Am J Hypertens 2015 Jan;28(1):30-41.
  32. The prognostic value of ambulatory arterial stiffness index as a predictor of cardiovascular events in resistant hypertensive patients? J Hypertens 2015 Jun;33(Suppl 1):e74.
  33. Ambulatory systolic-diastolic pressure regression index as a predictor of clinical events: a meta-analysis of longitudinal studies. Stroke 2012 Mar;43(3):733-739.
  34. Short-term blood pressure variability relates to the presence of subclinical brain small vessel disease in primary hypertension. Hypertension 2015 Sep;66(3):634-640.
  35. Visit-to-visit and ambulatory blood pressure variability as predictors of incident cardiovascular events in patients with hypertension. Am J Hypertens 2012 Sep;25(9):962-968.
  36. Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks. Hypertens Res 2016 May;39(5):277-292.
  37. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction. Chronobiol Int 2013 Mar;30(1-2):68-86.
  38. Chronic management of hypertension after stroke: the role of ambulatory blood pressure monitoring. J Stroke 2016 Jan;18(1):31-37.
  39. PROGRESS: prevention of recurrent stroke. J Clin Hypertens (Greenwich) 2011 Sep;13(9):693-702.
  40. Reverse dipper and high night-time heart rate in acute stage of cerebral infarction are associated with increased mortality. J Stroke Cerebrovasc Dis 2014 May-Jun;23(5):1171-1176.
  41. The role and chronobiometric study of ambulatory arterial pressure monitoring in hypertensive patients with a recent cerebral ischemia episode. Recenti Prog Med 1997 Sep;88(9):383-387.
  42. Assessment of blood pressure control in hypertensive stroke survivors: an ambulatory blood pressure monitoring study. Blood Press Monit 2006 Oct;11(5):235-241.
  43. Ambulatory blood pressure monitoring in stroke survivors: do we really control our patients? Eur J Intern Med 2009 Dec;20(8):760-763.
  44. Lack of nocturnal blood pressure fall in elderly bedridden hypertensive patients with cerebrovascular disease. Chronobiol Int 2012 Feb;29(1):62-65.
  45. Prognostic value of 24-h ABPM in acute ischemic stroke for short-, medium-, and long-term outcome: a systematic review and meta-analysis. Int J Stroke 2015 Oct;10(7):1000-1007.
  46. Brain edema formation is associated with the time rate of blood pressure variation in acute stroke patients. Blood Press Monit 2013 Aug;18(4):203-207.
  47. Ambulatory blood pressure monitoring in acute stroke: pathophysiology of the time rate of blood pressure variation and association with the 1-year outcome. Blood Press Monit 2013 Apr;18(2):94-100.
  48. Higher ambulatory blood pressure relates to new cerebral microbleeds: 2-year follow-up study in lacunar stroke patients. Stroke 2013 Apr;44(4):978-983.
  49. Effects of 24 hour blood pressure and heart rate recorded with ambulatory blood pressure monitoring on recovery from acute ischemic stroke. Stroke 2011 Dec;42(12):3511-3517.
  50. Can the treatment of arterial hypertension help to prevent dementia? Rev Neurol 2013 Jan;56(2):91-100.
  51. Level of systolic blood pressure within the normal range and risk of recurrent stroke. JAMA 2011 Nov;306(19):2137-2144.
  52. Low-Normal systolic blood pressure and secondary stroke risk. J Stroke Cerebrovasc Dis 2013 Jul;22(5):633-638.
  53. A follow-up study of blood pressure and cerebral white matter lesions. Ann Neurol 1999 Dec;46(6):827-833.
  54. Average daily blood pressure, not office blood pressure, is associated with progression of cerebrovascular disease and cognitive decline in older people. Circulation 2011 Nov 22;124(21):2312-2319.
  55. High blood pressure and cerebral white matter lesion progression in the general population. Hypertension 2013 Jun;61(6):1354-1359.
  56. Microalbuminurea as an index of brain microvascular dysfunction. J Neurol Sci 2008;272:34-35.
  57. Arnold AM, Bernick C, Bryan RN, Beauchamp NJ Jr. Cardiovascular Health Study Collaborative Research Group. White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke 2004 Aug;35(8):1821-1825.
  58. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol 2009 Feb;8(2):205-216.
  59. Older people with impaired mobility have specific loci of periventricular abnormality on MRI. Neurology 2002 Jan;58(1):48-55.
  60. White matter lesions and disequilibrium in older people. I. Case-control comparison. Arch Neurol 1995 Oct;52(10):970-974.
  61. Urinary function in elderly people with and without leukoaraiosis: relation to cognitive and gait function. J Neurol Neurosurg Psychiatry 1999;67(5):658-660.
  62. Leuko-araiosis on magnetic resonance imaging and speed of mental processing. Arch Neurol 1990 Feb;47(2):151-156.
  63. Localization of brain white matter hyperintensities and urinary incontinence in community-dwelling older adults. J Gerontol A Biol Sci Med Sci 2009 Aug;64(8):902-909.
  64. Demographic and biological influences on cognitive reserve. J Clin Exp Neuropsychol 2009 Oct;31(7):868-876.
  65. Brain regional lesion burden and impaired mobility in the elderly. Neurobiol Aging 2011 Apr;32(4):646-654.
  66. Mobility decline in the elderly relates to lesion accrual in the splenium of the corpus callosum. Age 2012 Apr;34(2):405-414.
  67. Long-term reproducibility of ambulatory blood pressure is superior to office blood pressure in the very elderly. J Hum Hypertens 2010 Nov;24(11):749-754.
  68. Nocturnal blood pressure epidemiology, determinants, and effects of antihypertensive therapy. Blood Press Monit 1998 Feb;3(1):43-51.
  69. INtensive versus standard ambulatory blood pressure lowering to prevent functional DeclINE in the Elderl Y (INFINITY). Am Heart J 2013 Mar;165(3):258-265.
  70. Treatment ofhypertension inpatients 80 years of age or older. N Engl J Med 2008 May 1;358(18):1887-1898.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.